As seen in the Physicians Desk Reference (PDR) since 2003
4Life Products Listed in Physicians Desk Reference
Transfer Factor Cardio and Transfer Factor Plus Listed
SANDY, UT (August 13, 2003) 4Life Research (4Life) announced today that Transfer Factor Cardio and Transfer Factor Plus are now listed in the Physicians Desk Reference for Nonprescription Drugs and Dietary Supplements (PDR). The PDR has been in use for over 57 years and is recognized as an unbiased reference source for physicians to research and recommend drugs and supplements.
The Nutritional Supplements Edition of the PDR lists Food and Drug Administration approved over-the-counter medicines and also includes a section on dietary supplements, vitamins and herbal remedies. The Transfer Factor Cardio and Transfer Factor Plus listings appearing on page 805 include a full description of the two products, a summary of research, directions for use and contact information for the company.
David Lisonbee, Chief Executive Officer of 4Life, commented, “4Life has taken a significant step by listing its tested and proven products in this important reference source. Our distributors can have the assurance that the same products they are recommending to family and friends are referenced and recommended by doctors and health care practitioners. This is especially important in foreign countries that rely heavily upon reputable sources such as the PDR when recommending products to prospective customers. As 4Life continues to grow domestically and in new foreign markets, our PDR entries will create immediate credibility for our new distributors to rely upon.”
4Life is aggressively growing in 16 countries, with plans of continued foreign expansion. This growth is part of the ongoing mission of the company of Taking Transfer Factor to the World.
4Life Research is the world’s foremost manufacturer and marketer of Transfer Factor products that are derived from eggs, as well as cow colostrum (first milk). 4Life Research holds exclusive patents on these products and processes.